Document is current
Any future updates will be listed below
-
Authors
Haque, Anamul
Stubbs, Doug
Hubig, Nina C.
Spinale, Francis G.
Richardson, William J.
-
Funding
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (HL144927)
National Institute of General Medical Sciences (GM121342)
- License Information
-
More Information
Article History
Received: 3 May 2022
Accepted: 4 October 2022
First Online: 31 October 2022
Declarations
:
: Our study used de-identified data from the SMART-AV clinical trial, wherein the original patients gave informed consent as approved by each participating institute’s institutional review board []. All methods were performed in accordance with relevant guidelines and regulations.
: Not applicable.
: AH, DS, and WJR have filed a provisional patent application related to biomarker-based patient selection for cardiac resynchronization therapy and the remaining authors have no competing interests.
